Oncopeptides AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-267.84	-284.61	-249.11	-337.95	-1,430	-1,595
Depreciation & Amortization	9.75	9.75	11.04	16.84	14.57	14.12
Other Amortization	-	-	-	0.32	0.42	0.28
Asset Writedown & Restructuring Costs	-	-	-	-	16.59	-
Stock-Based Compensation	10.91	10.91	11.5	14.81	14.54	38.92
Other Operating Activities	19.25	6.06	4.14	-3.84	-94.11	102.59
Change in Accounts Receivable	-4.3	-4.3	-16.02	53.17	24.66	-7.75
Change in Inventory	-1.95	-1.95	-2.42	-1.46	-0.32	-0.43
Change in Accounts Payable	3.15	3.15	-13.19	-22.89	-104.91	55.15
Change in Other Net Operating Assets	3.1	0.42	-25.42	-139.52	42.49	95.3
Operating Cash Flow	-227.93	-260.57	-279.49	-420.51	-1,516	-1,297
Capital Expenditures	-0.36	-0.36	-0.12	-2.51	-0.34	-17.18
Investment in Securities	0.85	0.85	-0	-	-	-3.13
Other Investing Activities	0	0	0	-	-	0.18
Investing Cash Flow	0.5	0.5	-0.12	-2.51	-0.34	-20.13
Long-Term Debt Repaid	-	-8.03	-9.14	-15.54	-15.41	-14.26
Net Debt Issued (Repaid)	-8.03	-8.03	-9.14	-15.54	-15.41	-14.26
Issuance of Common Stock	313.48	313.48	116.02	436.02	1,116	1,423
Other Financing Activities	-180.01	-41.64	-	-28.07	-67.05	-85.23
Financing Cash Flow	125.44	263.81	106.89	392.4	1,034	1,323
Foreign Exchange Rate Adjustments	-0.11	1.39	1.61	12.94	4.63	-92.76
Miscellaneous Cash Flow Adjustments	-0	-	-0	-	-0	-
Net Cash Flow	-102.1	5.13	-171.11	-17.67	-478.07	-85.93
Free Cash Flow	-228.28	-260.93	-279.61	-423.02	-1,517	-1,314
Free Cash Flow Margin	-365.46%	-824.47%	-793.89%	-5063.03%	-1282.16%	-
Free Cash Flow Per Share	-1.06	-1.57	-3.09	-5.14	-20.14	-21.06
Cash Interest Paid	0	0	0.57	0.88	0.95	1.49
Cash Income Tax Paid	-	-0.59	-1.65	0.04	12.22	7.24
Levered Free Cash Flow	-147.87	-169.03	-191.36	-289.31	-1,086	-699.92
Unlevered Free Cash Flow	-127.68	-161.12	-187.74	-288.76	-1,086	-698.99
Change in Working Capital	0	-2.68	-57.06	-110.69	-38.08	142.27

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.